相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The histone demethylase KDM5C functions as a tumor suppressor in AML by repression of bivalently marked immature genes
Mette Louise Trempenau et al.
LEUKEMIA (2023)
TET2 deficiency cooperates with CBFB-MYH11 to induce acute myeloid leukaemia and represents an early leukaemogenic event
Kristian Reckzeh et al.
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9
Friederike Christen et al.
LEUKEMIA (2022)
Focal disruption of DNA methylation dynamics at enhancers in IDH-mutant AML cells
Elisabeth R. Wilson et al.
LEUKEMIA (2022)
The UCSC Genome Browser database: 2022 update
Brian T. Lee et al.
NUCLEIC ACIDS RESEARCH (2022)
Tumor suppressor CEBPA interacts with and inhibits DNMT3A activity
Xiufei Chen et al.
SCIENCE ADVANCES (2022)
GATA2 deficiency elevates interferon regulatory factor-8 to subvert a progenitor cell differentiation program
Kirby D. Johnson et al.
BLOOD ADVANCES (2022)
Gata2-77 enhancer regulates adult hematopoietic stem cell survival
Xiaona You et al.
LEUKEMIA (2021)
TET2: A cornerstone in normal and malignant hematopoiesis
Hiroyoshi Kunimoto et al.
CANCER SCIENCE (2021)
Identification of gene targets of mutant C/EBPα reveals a critical role for MSI2 in CEBPA-mutated AML
Elizabeth Heyes et al.
LEUKEMIA (2021)
TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis
Morten Tulstrup et al.
NATURE COMMUNICATIONS (2021)
Allele-specific expression of GATA2 due to epigenetic dysregulation in CEBPA double-mutant AML
Roger Mulet-Lazaro et al.
BLOOD (2021)
p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia
Na Man et al.
JCI INSIGHT (2021)
Identification of therapeutic targets of the hijacked super-enhancer complex in EVI1-rearranged leukemia
Sandra Kiehlmeier et al.
LEUKEMIA (2021)
Disruption of a GATA2-TAL1-ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells
Julie A. I. Thoms et al.
BLOOD (2021)
CEBPA Mutations in 4708 Patients with Acute Myeloid Leukemia - Differential Impact of bZIP and TAD Mutations on Outcome
Franziska Taube et al.
BLOOD (2021)
Uncoupling key determinants of hematopoietic stem cell engraftment through cell-specific and temporally controlled recipient conditioning
Natsumi Miharada et al.
STEM CELL REPORTS (2021)
PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα
Evelyn Ramberger et al.
ISCIENCE (2021)
Companion gene mutations and their clinical significance in AML with double mutantCEBPA
Yang Zhang et al.
CANCER GENE THERAPY (2020)
CCAAT enhancer binding protein alpha (CEBPA) biallelic acute myeloid leukaemia: cooperating lesions, molecular mechanisms and clinical relevance
Anna S. Wilhelmson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
C/EBPα and GATA-2 Mutations Induce Bilineage Acute Erythroid Leukemia through Transformation of a Neomorphic Neutrophil-Erythroid Progenitor
Cristina Di Genua et al.
CANCER CELL (2020)
Loss of TET2 Affects Proliferation and Drug Sensitivity through Altered Dynamics of Cell-State Transitions
Leanna Morinishi et al.
CELL SYSTEMS (2020)
EVI1 and GATA2 misexpression induced by inv(3)(q21q26) contribute to megakaryocyte-lineage skewing and leukemogenesis
Ayaka Yamaoka et al.
BLOOD ADVANCES (2020)
From Basic Biology to Patient Mutational Spectra of GATA2 Haploinsufficiencies: What Are the Mechanisms, Hurdles, and Prospects of Genome Editing for Treatment
Cansu Koyunlar et al.
FRONTIERS IN GENOME EDITING (2020)
TET2 binding to enhancers facilitates transcription factor recruitment in hematopoietic cells
Kasper D. Rasmussen et al.
GENOME RESEARCH (2019)
CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex
Luisa Schmidt et al.
LEUKEMIA (2019)
CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing
Kornel Labun et al.
NUCLEIC ACIDS RESEARCH (2019)
Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AML
Cihangir Duy et al.
CANCER DISCOVERY (2019)
Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML
Janus S. Jakobsen et al.
SCIENCE ADVANCES (2019)
Non-catalytic Roles of Tet2 Are Essential to Regulate Hematopoietic Stem and Progenitor Cell Homeostasis
Kyoko Ito et al.
CELL REPORTS (2019)
Gata2 as a Crucial Regulator of Stem Cells in Adult Hematopoiesis and Acute Myeloid Leukemia
Juan Bautista Menendez-Gonzalez et al.
STEM CELL REPORTS (2019)
Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
Theodore P. Braun et al.
NATURE COMMUNICATIONS (2019)
The splicing factor RBM25 controls MYC activity in acute myeloid leukemia
Ying Ge et al.
NATURE COMMUNICATIONS (2019)
GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML
Ahad F. Al Seraihi et al.
LEUKEMIA (2018)
Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host
Marlies Meisel et al.
NATURE (2018)
Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on next-generation sequencing and its prognostic significance
Long Su et al.
Oncotarget (2018)
Enhancer and Transcription Factor Dynamics during Myeloid Differentiation Reveal an Early Differentiation Block in Cebpa null Progenitors
Sachin Pundhir et al.
CELL REPORTS (2018)
TET2 Loss Dysregulates the Behavior of Bone Marrow Mesenchymal Stromal Cells and Accelerates Tet2-/--Driven Myeloid Malignancy Progression
Rong Li et al.
STEM CELL REPORTS (2018)
Transcription Factors Drive Tet2-Mediated Enhancer Demethylation to Reprogram Cell Fate
Jose Luis Sardina et al.
CELL STEM CELL (2018)
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
Feng-Ming Tien et al.
BLOOD CANCER JOURNAL (2018)
Functional genomic landscape of acute myeloid leukaemia
Jeffrey W. Tyner et al.
NATURE (2018)
Genetic heterogeneity of cytogenetically normal AML with mutations of CEBPA
Nikola P. Konstandin et al.
BLOOD ADVANCES (2018)
Salmon provides fast and bias-aware quantification of transcript expression
Rob Patro et al.
NATURE METHODS (2017)
A screening system to identify transcription factors that induce binding site-directed DNA demethylation
Takahiro Suzuki et al.
EPIGENETICS & CHROMATIN (2017)
Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant
Jae-Sook Ahn et al.
ANNALS OF HEMATOLOGY (2016)
The multifaceted functions of C/EBPα in normal and malignant haematopoiesis
E. Ohlsson et al.
LEUKEMIA (2016)
Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia
Klaus H. Metzeler et al.
BLOOD (2016)
MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome
Vaia Stavropoulou et al.
CANCER CELL (2016)
Loss of c-Kit and bone marrow failure upon conditional removal of the GATA-2 C-terminal zinc finger domain in adult mice
Haiyan S. Li et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
John G. Doench et al.
NATURE BIOTECHNOLOGY (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Mutational Cooperativity Linked to Combinatorial Epigenetic Gain of Function in Acute Myeloid Leukemia
Alan H. Shih et al.
CANCER CELL (2015)
WT1 Recruits TET2 to Regulate Its Target Gene Expression and Suppress Leukemia Cell Proliferation
Yiping Wang et al.
MOLECULAR CELL (2015)
Acute loss of TET function results in aggressive myeloid cancer in mice
Jungeun An et al.
NATURE COMMUNICATIONS (2015)
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution
Hsin-An Hou et al.
ANNALS OF HEMATOLOGY (2015)
Mutational spectrum of myeloid malignancies with inv(3)/t(3;3) reveals a predominant involvement of RAS/RTK signaling pathways
Stefan Groeschel et al.
BLOOD (2015)
A Remote GATA2 Hematopoietic Enhancer Drives Leukemogenesis in inv(3)(q21;q26) by Activating EVI1 Expression
Hiromi Yamazaki et al.
CANCER CELL (2014)
A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia
Stefan Groeschel et al.
CELL (2014)
Initiation of MLL-rearranged AML is dependent on C/EBPα
Ewa Ohlsson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
The role of different genetic subtypes of CEBPA mutated AML
A. Fasan et al.
LEUKEMIA (2014)
Epigenetic regulation of GATA2 and its impact on normal karyotype acute myeloid leukemia
M. Celton et al.
LEUKEMIA (2014)
deepTools: a flexible platform for exploring deep-sequencing data
Fidel Ramirez et al.
NUCLEIC ACIDS RESEARCH (2014)
Easy quantitative assessment of genome editing by sequence trace decomposition
Eva K. Brinkman et al.
NUCLEIC ACIDS RESEARCH (2014)
DNA Hydroxymethylation Profiling Reveals that WT1 Mutations Result in Loss of TET2 Function in Acute Myeloid Leukemia
Raajit Rampal et al.
CELL REPORTS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
CEBPA double-mutated acute myeloid leukaemia harbours concomitant molecular mutations in 76•8% of cases with TET2 and GATA2 alterations impacting prognosis
Vera Grossmann et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
CG methylated microarrays identify a novel methylated sequence bound by the CEBPB|ATF4 heterodimer that is active in vivo
Ishminder K. Mann et al.
GENOME RESEARCH (2013)
GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis
A. Fasan et al.
LEUKEMIA (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia
Philipp A. Greif et al.
BLOOD (2012)
Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning
Kim-Chew Lim et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Tet2 Facilitates the Derepression of Myeloid Target Genes during CEBPα-Induced Transdifferentiation of Pre-B Cells
Eric M. Kallin et al.
MOLECULAR CELL (2012)
Landscape of TET2 mutations in acute myeloid leukemia
S. Weissmann et al.
LEUKEMIA (2012)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Peter A. Jones
NATURE REVIEWS GENETICS (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications
Felix Krueger et al.
BIOINFORMATICS (2011)
Quality control and preprocessing of metagenomic datasets
Robert Schmieder et al.
BIOINFORMATICS (2011)
TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis
Cyril Quivoron et al.
CANCER CELL (2011)
BigWig and BigBed: enabling browsing of large distributed datasets
W. J. Kent et al.
BIOINFORMATICS (2010)
BEDTools: a flexible suite of utilities for comparing genomic features
Aaron R. Quinlan et al.
BIOINFORMATICS (2010)
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Maria E. Figueroa et al.
CANCER CELL (2010)
Clinical, Molecular, and Prognostic Significance of WHO Type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and Various Other 3q Abnormalities in Acute Myeloid Leukemia
Sanne Lugthart et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
High EVI1 Expression Predicts Outcome in Younger Adult Patients With Acute Myeloid Leukemia and Is Associated With Distinct Cytogenetic Abnormalities
Stefan Groeschel et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
Sven Heinz et al.
MOLECULAR CELL (2010)
Coding of facial expressions of pain in the laboratory mouse
Dale J. Langford et al.
NATURE METHODS (2010)
A Single cis Element Maintains Repression of the Key Developmental Regulator Gata2
Jonathan W. Snow et al.
PLOS GENETICS (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid features
Maria E. Figueroa et al.
BLOOD (2009)
Modeling of C/EBP alpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells
Peggy Kirstetter et al.
CANCER CELL (2008)
Model-based Analysis of ChIP-Seq (MACS)
Yong Zhang et al.
GENOME BIOLOGY (2008)
Restoration of p53 function leads to tumour regression in vivo
Andrea Ventura et al.
NATURE (2007)
Probing tumor phenotypes using stable and regulated synthetic microRNA precursors
RA Dickins et al.
NATURE GENETICS (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis
NP Rodrigues et al.
BLOOD (2005)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
Transgenic mice with hematopoietic and lymphoid specific expression of Cre
J de Boer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
分享论文
